Monthly Archives: June 2024

The Impact of Dr. Satya Vadlamani’s Leadership on Murli Krishna Pharma

2024-08-10T01:25:03+05:30

Dr. Satya Vadlamani, CMD of Murli Krishna Pharma Pvt. Ltd. (MKPPL), has reshaped the pharmaceutical landscape in India with her unwavering dedication and strategic acumen. Armed with a degree in Electrical and Electronics Engineering, Ph.D and MBA in Strategic Management, and nearly three decades of experience in global pharmaceutical marketing, Dr. Vadlamani has propelled MKPPL to the forefront of the industry. 

The Impact of Dr. Satya Vadlamani’s Leadership on Murli Krishna Pharma2024-08-10T01:25:03+05:30

Murli Krishna Pharma: Vision & Mission for Anemia Mukt Bharat

2024-08-10T01:25:37+05:30

Murli Krishna Pharma Pvt. Ltd., a leading pharmaceutical company in India, has set its sights on a noble mission: to contribute to the eradication of anemia in the country. With its innovative solutions and unwavering commitment to quality, Murli Krishna Pharma is poised to play a significant role in the government's "Anemia Mukt Bharat" initiative.

Murli Krishna Pharma: Vision & Mission for Anemia Mukt Bharat2024-08-10T01:25:37+05:30

How Murli Krishna Pharma is Redefining Pharmaceutical Standards in India

2024-08-10T01:26:07+05:30

Murli Krishna Pharma Pvt. Ltd. excels in offering a diverse range of Pre-Finished Formulation Intermediates (PFI) and finished dosage forms that adhere to the highest quality standards. The company's PFI product range includes pellets and micro pellets designed for various formulations like capsules, injectables, tablets, and suspensions. These products come in different percentages, mesh sizes, and release types, catering to a wide array of medical needs.

How Murli Krishna Pharma is Redefining Pharmaceutical Standards in India2024-08-10T01:26:07+05:30
Go to Top